117 related articles for article (PubMed ID: 12831591)
1. Single dose application of cetrorelix in combination with clomiphene for friendly IVF: results of a feasibility study.
Engel JB; Olivennes F; Fanchin R; Frydman N; Le Dû A; Blanchet V; Frydman R
Reprod Biomed Online; 2003 Jun; 6(4):444-7. PubMed ID: 12831591
[TBL] [Abstract][Full Text] [Related]
2. The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate/gonadotrophin/0.25 mg cetrorelix.
Tavaniotou A; Albano C; Van Steirteghem A; Devroey P
Reprod Biomed Online; 2003 Jun; 6(4):421-6. PubMed ID: 12831586
[TBL] [Abstract][Full Text] [Related]
3. Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'?
Engel JB; Ludwig M; Felberbaum R; Albano C; Devroey P; Diedrich K
Hum Reprod; 2002 Aug; 17(8):2022-6. PubMed ID: 12151431
[TBL] [Abstract][Full Text] [Related]
4. Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles.
Hwang JL; Huang LW; Hsieh BC; Tsai YL; Huang SC; Chen CY; Hsieh ML; Chen PH; Lin YH
Hum Reprod; 2003 Jan; 18(1):45-9. PubMed ID: 12525439
[TBL] [Abstract][Full Text] [Related]
5. The use of clomiphene citrate/human menopausal gonadotrophins in conjunction with GnRH antagonist in an IVF/ICSI program is not a cost effective protocol.
Mansour R; Aboulghar M; Serour GI; Al-Inany HG; Fahmy I; Amin Y
Acta Obstet Gynecol Scand; 2003 Jan; 82(1):48-52. PubMed ID: 12580839
[TBL] [Abstract][Full Text] [Related]
6. Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF/ICSI cycles.
Lin YH; Seow KM; Hsieh BC; Huang LW; Chen HJ; Huang SC; Chen CY; Chen PH; Hwang JL; Tzeng CR
J Assist Reprod Genet; 2007 Aug; 24(8):331-6. PubMed ID: 17636445
[TBL] [Abstract][Full Text] [Related]
7. [Revisiting the clomifene-gonadotropin protocol in IVF with the use of a GnRH antagonist].
Emperaire JC; Parneix I; Perraguin-Jayot S
Gynecol Obstet Fertil; 2003 Nov; 31(11):927-31. PubMed ID: 14623556
[TBL] [Abstract][Full Text] [Related]
8. Effect of cetrorelix dose on premature LH surge during ovarian stimulation.
Lin YH; Seow KM; Chen HJ; Hsieh BC; Huang LW; Tzeng CR; Hwang JL
Reprod Biomed Online; 2008 Jun; 16(6):772-7. PubMed ID: 18549685
[TBL] [Abstract][Full Text] [Related]
9. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.
Rongières-Bertrand C; Olivennes F; Righini C; Fanchin R; Taïeb J; Hamamah S; Bouchard P; Frydman R
Hum Reprod; 1999 Mar; 14(3):683-8. PubMed ID: 10221695
[TBL] [Abstract][Full Text] [Related]
10. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
[TBL] [Abstract][Full Text] [Related]
11. Antagonist protocol versus clomiphene in unexplained infertility: A randomized controlled study.
Nada AM; ElSetohy KA; Banat MM; Shaheen AF
Taiwan J Obstet Gynecol; 2016 Jun; 55(3):326-30. PubMed ID: 27343309
[TBL] [Abstract][Full Text] [Related]
12. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
[TBL] [Abstract][Full Text] [Related]
13. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).
Olivennes F; Belaisch-Allart J; Emperaire JC; Dechaud H; Alvarez S; Moreau L; Nicollet B; Zorn JR; Bouchard P; Frydman R
Fertil Steril; 2000 Feb; 73(2):314-20. PubMed ID: 10685535
[TBL] [Abstract][Full Text] [Related]
14. [Protocol of GNRH antagonist in poor responders in IVF-ET cycles].
Grzechocińska B; Fracki S; Marianowski P; Dworniak T; Bablok L; Marianowski L
Ginekol Pol; 2003 Sep; 74(9):943-8. PubMed ID: 14674149
[TBL] [Abstract][Full Text] [Related]
15. Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study.
Lin YH; Hwang JL; Seow KM; Huang LW; Hsieh BC; Tzeng CR
Gynecol Endocrinol; 2006 Jun; 22(6):297-302. PubMed ID: 16785154
[TBL] [Abstract][Full Text] [Related]
16. Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols?
Craft I; Gorgy A; Hill J; Menon D; Podsiadly B
Hum Reprod; 1999 Dec; 14(12):2959-62. PubMed ID: 10601078
[TBL] [Abstract][Full Text] [Related]
17. Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist.
Tavaniotou A; Albano C; Smitz J; Devroey P
Fertil Steril; 2002 Apr; 77(4):733-7. PubMed ID: 11937125
[TBL] [Abstract][Full Text] [Related]
18. Menstrual cycle synchronization, ovarian stimulation, and in vitro fertilization in olive baboons (Papio anubis): a prospective randomized study.
Nyachieo A; Spiessens C; Chai DC; Mwenda JM; D'Hooghe TM
Fertil Steril; 2009 Feb; 91(2):602-10. PubMed ID: 18328482
[TBL] [Abstract][Full Text] [Related]
19. Controlled ovarian stimulation using a long gonadotropin-releasing hormone antagonist protocol: a proof of concept and feasibility study.
Weissman A; Ravhon A; Steinfeld Z; Nahum H; Golan A; Levran D
Gynecol Obstet Invest; 2013; 76(2):113-8. PubMed ID: 23920048
[TBL] [Abstract][Full Text] [Related]
20. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study.
Felberbaum RE; Albano C; Ludwig M; Riethmüller-Winzen H; Grigat M; Devroey P; Diedrich K
Hum Reprod; 2000 May; 15(5):1015-20. PubMed ID: 10783344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
